Inflammatory Bowel Diseases (IBD) are chronic inflammatory conditions that affect millions of people worldwide and can cause debilitating symptoms such as abdominal pain,...
Argentina has taken a bold step towards becoming a major player in the global cannabis market by creating a regulatory agency specifically designed...
The government of Japan is considering a revision of its Cannabis Control Law, which would allow the use of cannabis for medicinal purposes by...
Linnea SA obtained the narcotics license from Swissmedic, the Swiss equivalent of Infarmed IP, making it one of the first companies in Switzerland to be licensed...
The Arizona Supreme Court has ruled that maternal use of cannabis for morning sickness does not constitute child neglect, the National Organization for the Reform of...
The start of the year for cannabis giant Tilray, listed on the New York Stock Exchange Nasdaq, began with the announcement of a new company strategy. Second...
The unexpected seems to have happened in Brazil. After an intense week of demands, social mobilization seems to have had an effect on the Federal Council of Medicine...
SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new EU-GMP pharmaceutical facilities in Portugal, the company announced in a press release. So far they have been...
On the 26th of September, the report was supposed to be presented on the pilot project that was carried out in France, regarding the production of medicines to...
The Australian medicines regulator, the Therapeutic Goods Administration (TGA), has issued 73 infringement notices about claims by medical cannabis companies in their...